Arlington Trust’s Genmab GMAB Stock Holding History

Arlington Trust’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$659	Hold	24	–	–	﹤0.01%	767
2026 Q1	$644	Buy	+24	New	+$719	﹤0.01%	758

Other funds holding GMAB

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Arlington Trust's GMAB Position: Q2 2026 in Review

Arlington Trust held its Genmab (GMAB) position steady in Q2 2026 at 24 shares worth $659. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Arlington Trust first reported a position in GMAB in Q1 2026 and has held it in 2 quarters since. 40 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Arlington Trust held 24 shares of Genmab worth $659 as of Q2 2026.
Arlington Trust left its Genmab share count unchanged in Q2 2026.
Genmab made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #767 holding.
Arlington Trust first reported a position in Genmab in Q1 2026 and has held it in 2 quarters since.
40 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.